BCG Vaccine Provides Older People Protection Against Respiratory infections: Study

The study said that BCG provides powerful preventive action against several infections—possibly against COVID-19 as well

A study published in the journal Cell has found that the Bacille Calmette-Guerin (BCG) vaccine, which was originally developed as a protection against tuberculosis, provides powerful preventive action against several infections—possibly against COVID-19 as well.

Mihai Netea, study author, said in a statement, "Two years ago we started the ACTIVATE study, with the aim of showing whether BCG vaccination could protect against infections in vulnerable elderly people." The researchers also added that the vaccine also provides protection for the elderly against respiratory infections.

Noticeable Difference

According to the researchers, patients over 65 years of age who were admitted to the hospital were randomized to receive BCG or placebo vaccination at their discharge. "We followed them for a year to see if BCG could protect them against a broad range of infections," Netea said.

Vaccine (Representational picture) Pixabay

The team revealed that the ACTIVATE study had already started before the corona pandemic. A total of 198 elderly people were given either a placebo or a BCG vaccine upon discharge from the hospital.

During the research, there was a noticeable difference: in the placebo group, 42.3 percent of the elderly developed an infection, while this was the case in only 25 percent of the BCG group. Also, the BCG-vaccinated participants had their first infection on average 16 weeks after vaccination, compared to 11 weeks for the placebo group. There was no difference in side effects.

Protection Against Several Infections

"The most important observation was that BCG could mainly protect against respiratory infections: BCG-vaccinated elderly people had 75 percent fewer respiratory infections than the elderly who received placebo," said study co-coordinator J. Giamarellos-Bourboulis.

Although most protection seems to have been against respiratory infections of (probably) viral origin, whether or not BCG also works against COVID-19 has not yet been demonstrated, due to the low prevalence of COVID-19 in this study, the team said. However, the study does show that it is safe to give the BCG vaccination to the elderly and that it can protect them against various infections.

Several studies are underway that look specifically at the effects of BCG on COVID-19. Last month, a study published in the journal 'Cell Reports Medicine', revealed that the BCG vaccine has a general stimulating effect on the immune system and is, therefore, effective against COVID-19.

(With inputs from agencies)